Average Ratings 0 Ratings
Average Ratings 0 Ratings
Description
BIOiSIMTM represents a groundbreaking 'virtual drug development engine' that significantly enhances the drug development sector by effectively identifying drug compounds that are most likely to provide meaningful therapeutic benefits for various diseases or conditions. We provide an array of translational solutions that are tailored to meet the specific needs of your pre-clinical and clinical initiatives. Central to our offerings is the highly validated BIOiSIMTM platform, which supports the development of small molecules, large molecules, and viruses. This innovative platform is underpinned by extensive data derived from thousands of compounds across seven different species, resulting in a level of robustness that is uncommon in the field. Emphasizing human health outcomes, the heart of the platform features a translatability engine that seamlessly converts insights gained from different species. Importantly, the BIOiSIMTM platform can be deployed prior to the initiation of preclinical animal trials, facilitating earlier insights and potentially reducing the costs associated with outsourced experimentation. By integrating these advanced capabilities, we aim to streamline the drug development process and accelerate the journey from discovery to market.
Description
Experience seamless collaboration and knowledge sharing across your organization with a comprehensive platform that integrates all essential tools, allowing for secure workflows and the use of Phoenix-based applications alongside third-party software. With more than 6,000 researchers relying on Phoenix WinNonlin for non-compartmental analysis (NCA), toxicokinetic modeling, and pharmacokinetic and pharmacodynamic (PK/PD) modeling, it has become the preferred choice among biopharmaceutical companies, academic institutions, and 11 international regulatory bodies, including the US FDA, EMA, and PMDA. Additionally, the Phoenix Platform offers advanced features like population PK/PD (popPK) modeling through Phoenix NLME and Level A correlation capabilities provided by the Phoenix IVIVC Toolkit, while its Validation Suites enable rapid software validation in less than half an hour, ensuring efficiency and compliance. This powerful suite not only enhances research productivity but also fosters innovation by enabling users to streamline their workflows effectively.
API Access
Has API
No
API Access
Has API
No
Integrations
No details available.
Integrations
No details available.
Pricing Details
No price information available.
Free Trial
No
Free Version
No
Pricing Details
No price information available.
Free Trial
No
Free Version
No
Deployment
Web-Based
Yes
On-Premises
No
iPhone App
No
iPad App
No
Android App
No
Windows
No
Mac
No
Linux
No
Chromebook
No
Deployment
Web-Based
Yes
On-Premises
No
iPhone App
No
iPad App
No
Android App
No
Windows
No
Mac
No
Linux
No
Chromebook
No
Customer Support
Business Hours
Yes
Live Rep (24/7)
No
Online Support
Yes
Customer Support
Business Hours
Yes
Live Rep (24/7)
No
Online Support
Yes
Types of Training
Training Docs
Yes
Webinars
No
Live Training (Online)
Yes
In Person
Yes
Types of Training
Training Docs
Yes
Webinars
Yes
Live Training (Online)
No
In Person
No
Vendor Details
Company Name
VERISIMLife
Country
United States
Website
www.verisimlife.com/our-platform/
Vendor Details
Company Name
Certara
Founded
2008
Country
United States
Website
www.certara.com/software/phoenix-pkpd/